NECT - An Improved Treatment for Sleeping Sickness

FIRST PUBLISHED Jul 8, 2009

New hope for patients thanks to a successful partnership.

NECT is the first new, improved treatment option in 25 years for stage 2 (advanced stage) human African trypanosomiasis (HAT) also known as sleeping sickness. It consists of a simplified coadministration of nifurtimox, which is given orally, and eflornithine, which is given intravenously.

Find out more about NECT: http://www.dndi.org/treatments/nect-c-treatments/product-profile.html

Видео NECT - An Improved Treatment for Sleeping Sickness канала Drugs for Neglected Diseases initiative